Dermatology Department, Cairo University, Faculty of Medicine , Cairo , Egypt.
J Dermatolog Treat. 2014 Apr;25(2):137-41. doi: 10.3109/09546634.2012.698249. Epub 2012 Jul 25.
There have been no well-controlled studies evaluating the efficacy of combining 1540 nm nonablative fractional laser with percutaneous collagen induction (PCI) and trichloroacetic acid (TCA) 20% in the treatment of atrophic acne scars.
We hypothesized that combined alternating sessions of both modalities would show better results than each individual modality.
Thirty-nine patients with post acne atrophic scars were included in this study. Patients were randomly equally divided into three groups; group 1 was subjected to six sessions of PCI combined with TCA 20% in the same session, group 2 was subjected to six sessions of 1540 nm fractional laser and group 3 was subjected to combined alternating sessions of the previously mentioned two modalities.
Scar severity scores improved by a mean of 59.79% (95% CI 47.38-72.21) (p < 0.001) in group 1, a mean of 61.83% (95% CI 54.09-69.56) (p < 0.001) in group 2 and a mean of 78.27% (95% CI 74.39-82.15) (p < 0.001) in group 3. The difference in the degree of improvement was statistically significant when comparing the three groups using ANOVA test (p = 0.004).
The current work recommends combining 1540 nm nonablative fractional laser in alternation with PCI and TCA 20% in the treatment of atrophic acne scars.
目前尚无研究评估 1540nm 非剥脱性点阵激光联合经皮胶原诱导(PCI)和 20%三氯乙酸(TCA)治疗萎缩性痤疮瘢痕的疗效。
我们假设两种方式的交替联合治疗会比单一方式的治疗效果更好。
本研究纳入 39 例痤疮后萎缩性瘢痕患者。患者随机平均分为三组;第 1 组接受 6 次 PCI 联合 TCA 20%同期治疗,第 2 组接受 6 次 1540nm 点阵激光治疗,第 3 组接受两种方式的交替联合治疗。
第 1 组的瘢痕严重程度评分平均改善 59.79%(95%CI 47.38-72.21)(p<0.001),第 2 组平均改善 61.83%(95%CI 54.09-69.56)(p<0.001),第 3 组平均改善 78.27%(95%CI 74.39-82.15)(p<0.001)。方差分析(ANOVA)检验显示三组间改善程度差异有统计学意义(p=0.004)。
目前的研究工作推荐交替使用 1540nm 非剥脱性点阵激光联合 PCI 和 20%TCA 治疗萎缩性痤疮瘢痕。